Abstract. Lung cancer is the leading cause of cancer-associated mortality worldwide, although molecular imaging techniques, including fludeoxyglucose positron emission tomography, have markedly improved the diagnosis of lung cancer. HIWI is a member of the human piwi family, members of which are known for their roles in RNA silencing. HIWI has been shown to serve a crucial function in stem cell self-renewal, and previous studies have reported HIWI overexpression in lung cancers. Furthermore, HIWI has been proposed to regulate the maintenance of cancer stem cell populations in lung cancers. The present study investigated the mRNA and protein expression levels of HIWI in non-small cell lung cancer (NSCLC) specimens harvested from 57 patients, using reverse transcription-quantitative polymerase chain reaction and western blot analysis, respectively. Subsequently, the HIWI expression level was manipulated using gain-of-function and loss-of-function strategies, and the role of HIWI in the proliferation of human A549 NSCLC cells was investigated using Cell Counting Kit-8 and colony formation assays. The mRNA and protein expression levels of HIWI were significantly upregulated in the intratumor NSCLC specimens, as compared with the peritumor specimens. Furthermore, the mRNA and protein expression levels of HIWI in A549 cells were successfully manipulated using the two strategies. Overexpression and knockout of HIWI were associated with the promotion and inhibition of A549 cell proliferation, respectively. The results of the present study suggested that HIWI is overexpressed in NSCLC tissues and demonstrated that upregulation of HIWI may promote the growth of lung cancer cells; thus suggesting that HIWI may have an oncogenic role in lung cancer.
IntroductionLung cancer is the leading cause of cancer-associated mortality worldwide (1), among which non-small cell lung cancer (NSCLC) accounts for ~80% of all cases of lung cancer (2). The incidence of NSCLC in China has markedly increased over the past 5 years (3). At present, numerous clinical and molecular prognostic factors are considered in order to tailor therapies to particular subgroups of patients; however, treatment responses are routinely assessed by serial measurements of tumour sizes prior to and following treatment (4). Molecular imaging, which is a research and clinical tool that was developed >30 years ago (5), has markedly improved the diagnosis and the treatment of lung cancers. Previous studies have suggested the superior prognostic value of fludeoxyglucose positron emission tomography, as compared with computed tomography, and it has exhibited enhanced sensitivity for the evaluation of therapeutic effects (6-8). However, NSCLC is typically diagnosed at the advanced stages, leading to a poor prognosis in China (9).The hiwi gene, which is a human homologue of the piwi family, is located at 12q24.33 and encodes the 98.5 kDa HIWI protein (10). The piwi family has been shown to have an important role in stem cell self-renewal in diverse organisms, including je...